Department of Radiology
Found 12 results
Filters: Author is Kaplitt, Michael G  [Clear All Filters]
2023
Unda SR, Marongiu R, Pomeranz LE, Dyke JP, Fung EK, Grosenick L, Zirkel R, Antoniazzi AM, Norman S, Liston CM et al..  2023.  Bidirectional Regulation of Motor Circuits Using Magnetogenetic Gene Therapy.. bioRxiv.
Ebani EJ, Strauss S, Thomas C, RoyChoudhury A, Kaplitt MG, J Chazen L.  2023.  Cranial MRgFUS intraprocedural diffusion and T2 imaging and comparison with postablation lesion size and location.. J Neurosurg. 139(4):1190-1194.
2020
Ebani EJ, Kaplitt MG, Wang Y, Nguyen TD, Askin G, J Chazen L.  2020.  Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease.. Clin Imaging. 68:94-98.
2019
Parker WE, Weidman EK, J Chazen L, Niogi SN, Uribe-Cardenas R, Kaplitt MG, Hoffman CE.  2019.  Magnetic resonance-guided focused ultrasound for ablation of mesial temporal epilepsy circuits: modeling and theoretical feasibility of a novel noninvasive approach.. J Neurosurg. :1-8.
2018
Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Arbona RJRicart, Monette S et al..  2018.  AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease.. Hum Gene Ther Clin Dev. 29(1):24-47.
J Chazen L, Sarva H, Stieg PE, Min RJ, Ballon DJ, Pryor KO, Riegelhaupt PM, Kaplitt MG.  2018.  Clinical improvement associated with targeted interruption of the cerebellothalamic tract following MR-guided focused ultrasound for essential tremor.. J Neurosurg. 129(2):315-323.
Stavarache MA, Petersen N, Jurgens EM, Milstein ER, Rosenfeld ZB, Ballon DJ, Kaplitt MG.  2018.  Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound.. J Neurosurg. 130(3):989-998.
2017
Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al..  2017.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.
2013
Liu T, Eskreis-Winkler S, Schweitzer AD, Chen W, Kaplitt MG, A Tsiouris J, Wang Y.  2013.  Improved subthalamic nucleus depiction with quantitative susceptibility mapping.. Radiology. 269(1):216-23.
2012
Sondhi D, Johnson L, Purpura K, Monette S, Souweidane MM, Kaplitt MG, Kosofsky B, Yohay K, Ballon D, Dyke J et al..  2012.  Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther Methods. 23(5):324-35.
2008
Worgall S, Sondhi D, Hackett NR, Kosofsky B, Kekatpure MV, Neyzi N, Dyke JP, Ballon D, Heier L, Greenwald BM et al..  2008.  Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.. Hum Gene Ther. 19(5):463-74.
2005
Arkin LM, Sondhi D, Worgall S, Suh LHyon K, Hackett NR, Kaminsky SM, Hosain SA, Souweidane MM, Kaplitt MG, Dyke JP et al..  2005.  Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders.. Hum Gene Ther. 16(9):1028-36.